En leverkarcinogen vars verkningsmekanism innebär N-hydroxylering till arylhydroxamsyra följt av enzymatisk sulfonering till sulfoxyfluorenylacetamid. Den används för att studera de karcinogena och mu tagena egenskaperna hos aromatiska aminer.
A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
Inga svenska synonymer finns.
2 Acetylaminofluorene — 2-Acetamidofluorene — 2 Acetamidofluorene — 2-Fluorenylacetamide — 2 Fluorenylacetamide — N-2-Fluorenylacetamide — N 2 Fluorenylacetamide — N-Acetyl-2-Aminofluorene — N Acetyl 2 Aminofluorene — AAF, Aminofluorene — Aminofluorene AAF — 2-AAF — Fluoren-2-ylacetamide — Fluoren 2 ylacetamide — Acetylaminofluorene